“Comparative Efficacy and Safety of Daily Versus Alternate Day Dosing of Rosuvastatin in Dyslipidemic Patients: A Prospective, Randomized, Open Label Study”. International Journal of Public Research in Medicine and Health 1, no. 1 (September 26, 2025): 10–19. Accessed April 19, 2026. https://ijprmh.com/journal/index.php/ijprmh/article/view/4.